How Interferon-β Helps Dendritic Cells Fight Influenza Virus
Author Information
Author(s): Phipps-Yonas Hannah, Seto Jeremy, Sealfon Stuart C., Moran Thomas M., Fernandez-Sesma Ana
Primary Institution: Mount Sinai School of Medicine, New York, New York, United States of America
Hypothesis
Type I interferon enhances the activation of dendritic cells in response to influenza virus infection.
Conclusion
Interferon-β pretreatment significantly boosts the activation of both conventional and plasmacytoid dendritic cells during influenza virus infections.
Supporting Evidence
- Type I interferon is crucial for initiating an antiviral state in cells.
- Both conventional and plasmacytoid dendritic cells showed enhanced activation when pre-exposed to interferon-β.
- Interferon-β treatment allowed dendritic cells to bypass the activation block caused by the influenza virus NS1 protein.
- Different kinetics of activation were observed between conventional and plasmacytoid dendritic cells.
Takeaway
When dendritic cells are exposed to a protein called interferon-β before they meet the flu virus, they become much better at fighting the virus.
Methodology
The study examined the activation profiles of dendritic cells in response to influenza virus in the presence of interferon-β, measuring gene expression and protein secretion.
Limitations
The study primarily focused on in vitro conditions, which may not fully replicate the in vivo environment.
Participant Demographics
Human dendritic cells derived from healthy donors.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website